Summary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded…
BioNtech
-
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
Synopsis : Pfizer Inc. (NYSE: PFE) Pfizer stands with the unified global community across the public, private and civil society sectors in…
-
BioNTechCompaniesGlobal MarketPharma Science & Research
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
by adminby adminSummary – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing on the…
-
Global MarketPharma Science & Research
First study to show waning effectiveness of 3rd dose of mRNA vaccines
by adminby adminSummary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…
-
CompaniesPfizerRegulatoryU.S FDA
FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids
by adminby adminSummary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…
-
Agrochemicals
Bharat Biotech gets nod for nasal Covid-19 vaccine’s phase-3 clinical trials- DCGI
by adminby adminSynopsis : Vaccine maker Bharat Biotech said that its nasal Covid-19 vaccine has been approved by the drug regulator for phase 3…
-
Agrochemicals
Delta variant, waning immunity reduced Pfizer vaccine’s effectiveness against household transmission
by adminby adminSummary : A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91%…
-
AgrochemicalsBioNTechGlobal Market
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50%
by adminby adminSummary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
-
CompaniesGlobal MarketPfizerPharma Science & Research
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…